Health Care: Drugs

Vical Inc (VICL: NASDAQ)

$1.3 -0.01 | -0.76%
07/22/14 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 1.21
52 Week High 4.51
52 Week Low 1.01
Avg. Daily Vol. (Mil) 0.95
Beta (3 year) 2.66
Share Related Items
Mkt Cap (Mil) 105.07
Shares Out (Mil) 86.84
Float (Mil) 77.55
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 15.70
Current Ratio 16.60
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 12.23
Price/Book 1.79
Price/Cash Flow -4.50
Per Share Data
Earnings -0.29
Sales 0.10
Book Value 0.68
Cash Flow -0.27
Business Summary
Vical Inc researches and develops biopharmaceutical products based on its patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases.
General Information
10390 Pacific Center Court
San Diego, CA 92121-4340
www.vical.com
Industry : Drugs
Sector: Health Care
Employees: 67
CEO: Mr. Vijay B. Samant
Short Interest
Current Month (Mil) 6.02
Previous Month (Mil) 4.80
Short Interest Ratio (Days) 5.20
Management Effectiveness
Return on Equity n.a.
Return on Assets -40.20
Return on Investments -43.30
Profitability
Gross Margin 20.70
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with VICL

Latest VICL Headlines from TheStreet

More Financial News for VICL

Press Releases for VICL

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter